The drug fulvestrant (Faslodex) has not been recommended in England to treat late stage breast cancer, in draft guidance.
Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment.
A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study.
Frozen needles, a smokefree UK, microbubbles and how scientists in the US are trying to break cancer cells’ ‘legs’. Here’s our weekly news report.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF